SCHEMBL6312167

SCHEMBL6312167

Cc1c(-c2ccccc2)c(N2CC(N(C)C(=O)OC(C)(C)C)C2)n2c(nc3ncccc32)c1C#N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.36
CASP1 P29466 2/20 0.36
HSD17B10 Q99714 2/20 0.36
HPGD P15428 2/20 0.36
TSHR P16473 1/20 0.36
CASP7 P55210 1/20 0.36
PDE10A Q9Y233 1/20 0.35
RET P07949 1/20 0.35
AAK1 Q2M2I8 1/20 0.35
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
NPSR1 Q6W5P4 2/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33
PRF1 P14222 1/20 0.33
BUB1 O43683 1/20 0.32
KDM4E B2RXH2 3/20 0.32
GLA P06280 2/20 0.32
GAA P10253 2/20 0.32
RXFP1 Q9HBX9 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6311018 0.85 HSD17B10 (0.38) ALDH1A1CASP1HSD17B10HPGDTSHR
SCHEMBL6318849 0.81 CASP1 (0.38) ALDH1A1CASP1HSD17B10CASP7MEN1
SCHEMBL6311573 0.79 HSD17B10 (0.38) ALDH1A1CASP1HSD17B10HPGDTSHR
SCHEMBL6312893 0.77 KCNMA1 (0.39) ALDH1A1CASP1HSD17B10HPGDTSHR
SCHEMBL6318649 0.76 ALDH1A1 (0.41) ALDH1A1CASP1HSD17B10HPGDTSHR
SCHEMBL6651720 0.75 HSD17B10 (0.38) ALDH1A1CASP1HSD17B10HPGDTSHR
SCHEMBL6319707 0.74 HSD17B10 (0.38) ALDH1A1CASP1HSD17B10HPGDTSHR
SCHEMBL6320383 0.73 ALDH1A1 (0.51) ALDH1A1CASP1HSD17B10HPGDTSHR
SCHEMBL6310374 0.71 ALDH1A1 (0.43) ALDH1A1CASP1HSD17B10HPGDTSHR
SCHEMBL6392201 0.71 MAPK8 (0.40) ALDH1A1MEN1KMT2ANPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 ALDH1A1 2550/4885CASP1 261/4885HSD17B10 4223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.